Book Value per Share: American Oncology Network Inc (AONC)

Public company logo of American Oncology Network (AONC)

American Oncology Network is expanding its network of regional centers by leveraging unique IT compliance and direct relationships with insurance companies. This historical book value per share chart allows for an assessment of the asset's margin of safety, while -16.20 captures the magnitude of this parameter. Long-term contracts with physicians ensure revenue stability, while the digitalization of routine processes and the implementation of molecular testing define the company's growth trajectory.

AON (AONC) - Accounting Value per Share from 02/21/2024 to 08/04/2024
Manufactured product of American Oncology Network Inc

American Oncology Network (AONC) diversification through clinic consolidation and the development of IT services is reflected in the book value dynamics of the common share, capturing real capital growth. This indicator is calculated as the difference between total assets and liabilities divided by the number of shares, allowing investors to assess the intrinsic value of the business and the risk of overpaying during market revaluations.

Competitor analysis for American Oncology Network

BeiGene Corp (ONC) - Net Assets per Single Share|HALO - Equity per Share|RVMD (Revolution Medicines) - Book Value per Share|ascentage.com (AAPG) - Accounting Value per Share|Book Value per Share CGON|Accounting Value per Share UroGen Pharma Ltd|Book Value per Share BCAX|Book Value per Share PSNL (Personalis Genomics)|ERAS - Net Assets per Single Share|Equity per Share delcath.com DCTH|YMAB: Book Value per Share|AURA - Accounting Value per Share|Book Value per Share CADL|ARAY (Accuray, Inc.) - Net Asset Value per Share|SLS - Net Assets per Single Share|Accounting Value of a Share actuatetherapeutics.com (ACTU)|Citius Oncology (CTOR) - Accounting Value per Share|Accounting Value of a Share tuhurabio.com (HURA)|Protara - Book Value per Share|FATE - Accounting Value per Share|Aadi Bio - Accounting Value per Share|TCRX: Book Value per Share|Net Assets per Single Share championsoncology.com CSBR|XBiotech (XBIT) - Accounting Value of a Share|Book Value per Share CVM (CEL-SCI Corp.)|Net Asset Value per Share OS Therapies, Inc.|Book Value per Share RADX|Book Value per Share ARTV (artivabio.com)|Adlai Nortye - Net Assets per Single Share|Accounting Value per Share Veru Inc VERU|TPST (Tempest Tx) - Book Value per Share|XLO: Net Asset Value per Share|Net Assets per Single Share renovarobio.com RENB|Mural Oncology (MURA) - Accounting Value of a Share|KAPA: Book Value per Share|Net Assets per Share OnKure|Book Value per Share GDTC (CytoMed Therapeutics)|Accounting Value per Share curis.com (CRIS)|Book Value per Share APLM (Apollomics)|tharimmune.com - Book Value per Share|Advanced Biomed Corp (ADVB) - Net Assets per Single Share|Genprex Inc. (GNPX) - Equity per Share|Accounting Value per Share calidibio.com CLDI|SBFM (Sunshine Biopharma Inc.) - Accounting Value of a Share|Net Assets per Single Share XBIO (Xenetic Biosciences Inc.)|Net Asset Value per Share SLRX|Net Assets per Single Share Purple Biotech Ltd. PPBT|Equity per Share BeiGene Ltd. (BGNE)|Checkpoint Therapeutics, Inc - Book Value per Share|elevationoncology.com - Accounting Value per Share|ICAD (iCAD Corp) - Net Assets per Single Share|IKNA: Net Asset Value per Share|Notable Labs (NTBL) - Net Assets per Single Share|VIRX (Viracta Therapeutics, Inc.) - Net Assets per Single Share|Net Assets per Single Share MOR (MorphoSys Corp)|Net Asset Value per Share NAYA Biosciences Corp|AAPGV: Book Value per Share